Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report

Janus kinase (JAK) inhibitors may be a promising therapeutic option for patients with twenty-nail dystrophy.

Authors

Institutions

Publication Details

Journal
Journal of Dermatological Treatment
Published
2025-09-25
DOI
https://doi.org/10.1080/09546634.2025.2562314
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report

Wenjun Zhao, Dongmei Liu, Shijun Shan
Journal of Dermatological Treatment
Cutaneous lymphoproliferative disorders research
article

Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report

Wenjun Zhao, Dongmei Liu, Shijun Shan
article en

Abstract

Janus kinase (JAK) inhibitors may be a promising therapeutic option for patients with twenty-nail dystrophy.

Journal of Dermatological TreatmentVol. 36(1)
Fifth Hospital of Shijiazhuang (CN), Jinhua Central Hospital (CN)
Openalex Percentile: Top 54%
Cutaneous lymphoproliferative disorders research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report — Wenjun Zhao, Dongmei Liu, et al. · Journal of Dermatological Treatment (2025) | TGRS Research Map | TGRS